# Angiotensin 1-7 in Obesity Hypertension

> **NCT03604289** · EARLY_PHASE1 · TERMINATED · sponsor: **Amy Arnold** · enrollment: 8 (actual)

## Conditions studied

- Obesity
- Hypertension

## Interventions

- **DRUG:** Angiotensin-(1-7)
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT03604289
- **Lead sponsor:** Amy Arnold
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-04-01
- **Primary completion:** 2023-05-03
- **Final completion:** 2023-06-03
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Funding terminated
- **Last updated:** 2024-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03604289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03604289, "Angiotensin 1-7 in Obesity Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03604289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*